% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Maida:125325,
author = {A. Maida and J. S. K. Chan and K. A. Sjøberg and A.
Zota$^*$ and D. Schmoll and B. Kiens and S. Herzig$^*$ and
A. J. Rose},
title = {{R}epletion of branched chain amino acids reverses m{TORC}1
signaling but not improved metabolism during dietary protein
dilution.},
journal = {Molecular metabolism},
volume = {6},
number = {8},
issn = {2212-8778},
address = {Oxford [u.a.]},
publisher = {Elsevier},
reportid = {DKFZ-2017-01458},
pages = {873 - 881},
year = {2017},
abstract = {Dietary protein dilution (PD) has been associated with
metabolic advantages such as improved glucose homeostasis
and increased energy expenditure. This phenotype involves
liver-induced release of FGF21 in response to amino acid
insufficiency; however, it has remained unclear whether
dietary dilution of specific amino acids (AAs) is also
required. Circulating branched chain amino acids (BCAAs) are
sensitive to protein intake, elevated in the serum of obese
humans and mice and thought to promote insulin resistance.
We tested whether replenishment of dietary BCAAs to an
AA-diluted (AAD) diet is sufficient to reverse the
glucoregulatory benefits of dietary PD.We conducted AA
profiling of serum from healthy humans and lean and high
fat-fed or New Zealand obese (NZO) mice following dietary
PD. We fed wildtype and NZO mice one of three amino acid
defined diets: control, total AAD, or the same diet with
complete levels of BCAAs (AAD + BCAA). We quantified serum
AAs and characterized mice in terms of metabolic efficiency,
body composition, glucose homeostasis, serum FGF21, and
tissue markers of the integrated stress response (ISR) and
mTORC1 signaling.Serum BCAAs, while elevated in serum from
hyperphagic NZO, were consistently reduced by dietary PD in
humans and murine models. Repletion of dietary BCAAs
modestly attenuated insulin sensitivity and metabolic
efficiency in wildtype mice but did not restore
hyperglycemia in NZO mice. While hepatic markers of the ISR
such as P-eIF2α and FGF21 were unabated by dietary BCAA
repletion, hepatic and peripheral mTORC1 signaling were
fully or partially restored, independent of changes in
circulating glucose or insulin.Repletion of BCAAs in dietary
PD is sufficient to oppose changes in somatic mTORC1
signaling but does not reverse the hepatic ISR nor induce
insulin resistance in type 2 diabetes during dietary PD.},
cin = {A170 / A171},
ddc = {610},
cid = {I:(DE-He78)A170-20160331 / I:(DE-He78)A171-20160331},
pnm = {323 - Metabolic Dysfunction as Risk Factor (POF3-323)},
pid = {G:(DE-HGF)POF3-323},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:28752051},
pmc = {pmc:PMC5518726},
doi = {10.1016/j.molmet.2017.06.009},
url = {https://inrepo02.dkfz.de/record/125325},
}